Additionally, PNPLA3 and TM6SF2 variants based genetic predisposition to liver scarring data in CHC patients is mainly available for different Caucasian ethnic groups with scarce representation of other populations, together with Indo-Pak region and mixed populations [18]. The gene discussed is PNPLA3; the disease is cryohydrocytosis.